IL76247A0 - Monoclonal antibodies to glycoconjugates,their production,their use and pharmaceutical compositions containing them,hybridoma cell lines secreting said antibodies and their preparation - Google Patents

Monoclonal antibodies to glycoconjugates,their production,their use and pharmaceutical compositions containing them,hybridoma cell lines secreting said antibodies and their preparation

Info

Publication number
IL76247A0
IL76247A0 IL76247A IL7624785A IL76247A0 IL 76247 A0 IL76247 A0 IL 76247A0 IL 76247 A IL76247 A IL 76247A IL 7624785 A IL7624785 A IL 7624785A IL 76247 A0 IL76247 A0 IL 76247A0
Authority
IL
Israel
Prior art keywords
antibodies
glycoconjugates
preparation
production
pharmaceutical compositions
Prior art date
Application number
IL76247A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848421944A external-priority patent/GB8421944D0/en
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IL76247A0 publication Critical patent/IL76247A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL76247A 1984-08-30 1985-08-29 Monoclonal antibodies to glycoconjugates,their production,their use and pharmaceutical compositions containing them,hybridoma cell lines secreting said antibodies and their preparation IL76247A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848421944A GB8421944D0 (en) 1984-08-30 1984-08-30 Monoclonal antibodies
GB858515538A GB8515538D0 (en) 1984-08-30 1985-06-19 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
IL76247A0 true IL76247A0 (en) 1986-01-31

Family

ID=26288164

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76247A IL76247A0 (en) 1984-08-30 1985-08-29 Monoclonal antibodies to glycoconjugates,their production,their use and pharmaceutical compositions containing them,hybridoma cell lines secreting said antibodies and their preparation

Country Status (11)

Country Link
EP (1) EP0173648A3 (no)
AU (1) AU4688785A (no)
DK (1) DK391785A (no)
ES (2) ES8703895A1 (no)
FI (1) FI853283L (no)
GR (1) GR852099B (no)
HU (1) HUT38391A (no)
IL (1) IL76247A0 (no)
NO (1) NO853397L (no)
NZ (1) NZ213293A (no)
PT (1) PT81040B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202252A (en) * 1982-03-05 1993-04-13 Houston Biotechnology Inc. Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
DE3783211T2 (de) * 1986-11-04 1993-04-29 Baylor College Medicine Zusammensetzungen zur verhuetung sekundaeren grauen stars.
US5055291A (en) * 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts
US5616122A (en) * 1986-11-04 1997-04-01 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US5104652A (en) * 1986-11-13 1992-04-14 Sloan-Kettering Institute For Cancer Research Compositions and method for treatment of cancer using monoclonal antibody against GD3 ganglioside together with IL-2
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
EP0280358B1 (en) * 1987-02-20 1992-12-30 Akzo N.V. Stabilized aqueous composition containing antibodies
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
WO1989002599A1 (en) * 1987-09-08 1989-03-23 The Biomembrane Institute Detection of survived, undegraded carbohydrate epitopes as diagnostic of intestinal diseases
US5030723A (en) * 1988-05-31 1991-07-09 The Biomembrane Institute Long-chain glycolipid structure
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
AU781171B2 (en) * 1997-06-10 2005-05-12 Lpath Therapeutics, Inc. Methods for early detection of heart disease
EP1363643A2 (en) * 2000-12-22 2003-11-26 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9217749B2 (en) 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
US8796429B2 (en) 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
AU2007313822A1 (en) 2006-10-27 2008-05-08 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
CA2667574A1 (en) 2006-10-27 2008-06-12 Roger A. Sabbadini Compositions and methods for binding sphingosine-1-phosphate
US8361465B2 (en) * 2007-10-26 2013-01-29 Lpath, Inc. Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
EP0209493A3 (en) * 1985-07-16 1988-05-04 Ciba-Geigy Ag Prophylaxis and treatment of whooping cough

Also Published As

Publication number Publication date
FI853283A0 (fi) 1985-08-28
ES8703895A1 (es) 1987-03-01
ES546564A0 (es) 1987-03-01
DK391785D0 (da) 1985-08-29
NZ213293A (en) 1988-11-29
FI853283L (fi) 1986-03-01
AU4688785A (en) 1986-03-06
HUT38391A (en) 1986-05-28
EP0173648A2 (en) 1986-03-05
ES8800845A1 (es) 1987-12-01
EP0173648A3 (en) 1988-04-27
ES555613A0 (es) 1987-12-01
PT81040B (en) 1987-06-24
NO853397L (no) 1986-03-03
DK391785A (da) 1986-03-01
PT81040A (en) 1985-09-01
GR852099B (no) 1986-01-02

Similar Documents

Publication Publication Date Title
IL76247A0 (en) Monoclonal antibodies to glycoconjugates,their production,their use and pharmaceutical compositions containing them,hybridoma cell lines secreting said antibodies and their preparation
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
IL79719A (en) Pharmaceutical composition comprising monoclonal antibodies binding determinants of gram negative bacteria and hybridoma cell lines producing the antibodies
DE3573922D1 (en) Monoclonal antibody directed to human ganglioside gd 2?
IL62965A0 (en) Monoclonal antibodies to drugs and theri production
DE3379406D1 (en) Hybridoma cell lines and monoclonal antibodies to theophylline
EP0174204A3 (en) Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof
IL75794A0 (en) Aminophenol compounds,their preparation and pharmaceutical compositions containing them
IL77052A (en) Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them
GB2134134B (en) Novel cell lines for use in the preparation of hybridoma cells
IL74043A (en) 8alhpa-acylaminoergolines,their production and pharmaceutical compositions containing them
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
IL83047A0 (en) Monoclonal antibodies to pseudomonas aerigunosa flagella,method and cell line for their production and pharmaceutical compositions containing them
EP0159025A3 (en) Monoclonal antibody specific to human alpha2-plasmin
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
IL63323A0 (en) Pentapeptides,their production and pharmaceutical compositions containing them
IL71702A0 (en) Biologically active polypeptides,their preparation,antibodies thereto and compositions containing them
EP0306680A3 (en) Monoclonal antibodies to anti-thrombin binding substance, and their uses
EP0166356A3 (en) 2-substituted-aminomethyl-1,4-benzodiazepines, process for their preparation and pharmaceutical compositions containing them
GB2169291B (en) 8a-acylaminoergolines, their production and pharmaceutical compositions containing them
IL75468A (en) Naphthoxazines,their production and pharmaceutical compositions containing them
IL85471A0 (en) Monoclonal antibodies to human pancreatic cancer,their production and hybridoma cell lines secreting them
IL75793A0 (en) Monoclonal antibodies against human ifn-ypsilon,their preparation and their use and hybrid cell lines producing these antibodies
IL78871A0 (en) Monoclonal antibodies,hybridoma cell lines and their preparation
ZA851373B (en) Diazepinoindoles,their production and pharmaceutical compositions containing them